Malignant Melanoma With Neuroendocrine Differentiation: A Case Report and Literature Review
BackgroundMelanoma has a wide range of histologic variants and cytomorphologic features that make its diagnosis challenging. Melanoma can also rarely have neuroendocrine markers adding further diagnostic uncertainty particularly given that unrelated tumor types, such as prostate cancer, can also dis...
Guardado en:
Autores principales: | Jason Cham, Ayal Shavit, Aren Ebrahimi, Miguel Viray, Paul Gibbs, Munveer S. Bhangoo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5df484e4c2ba4f82b8daef6c02eb2f9d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and Safety of PD-1 Inhibitor Combined with Anlotinib on Advanced Neuroendocrine Carcinoma
por: YU Xuxu, et al.
Publicado: (2021) -
Progress of Immune Checkpoint Inhibitors
in the Treatment of Advanced Pulmonary Neuroendocrine Tumors
por: Haoqing CHEN, et al.
Publicado: (2021) -
Imaging of Neuroendocrine Prostatic Carcinoma
por: Ahmed Taher, et al.
Publicado: (2021) -
Melanoma in situ colonizing basal cell carcinoma: a case report and review of the literature
por: Silvia E. Mancebo, et al.
Publicado: (2015) -
Genomic analyses of high‐grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities
por: Haider Mahdi, et al.
Publicado: (2021)